In May, Nofolk-based Sanyal Biotechnology became one of few U.S. companies to receive licensing to import cannabidiol (CBD) for medical research and clinical trials. CBD is an oil extracted from hemp ...
Nina Chamlou is a writer, interviewer and storyteller from Portland, Oregon. She covers technology, healthcare, psychology, mental health and social justice issues. Her motto is that useful info ...
Cardiol Therapeutics receives notice of allowance for its patent application from US PTO: Toronto Saturday, November 15, 2025, 15:00 Hrs [IST] Cardiol Therapeutics Inc, a Toronto- ...
Uncover how this plant-derived compound could revolutionize cognitive health, offering new hope for anxiety and cognitive impairment - if future research confirms its full potential. Study: ...
Hosted on MSN
Cannabidiol shows potential to reverse some neuropsychological effects of social stress
A new study published in Neuropharmacology provides evidence that cannabidiol, a non-psychoactive compound found in cannabis, may help buffer against the lasting psychological and neurobiological ...
A study led by the UAB Institut de Neurociències and published in the journal Nature Communications demonstrates in animal models how daily administration of cannabidiol (CBD), a substance obtained ...
Cannabis is a Schedule I drug, meaning the federal government doesn’t find it to be medically useful. That sentiment isn’t ...
Researchers from the University of Rochester and Harvard Medical School developed a nano-micelle CBD formulation that rapidly ...
PHILADELPHIA — New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback